A detailed history of Ifg Advisory, LLC transactions in Geron Corp stock. As of the latest transaction made, Ifg Advisory, LLC holds 10,000 shares of GERN stock, worth $36,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$36,600
Previous $42,000 7.14%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$1.75 - $3.44 $17,500 - $34,400
10,000 New
10,000 $33,000
Q4 2018

Feb 07, 2019

SELL
$0.98 - $1.85 $18,032 - $34,040
-18,400 Closed
0 $0
Q3 2018

Nov 05, 2018

BUY
$1.76 - $6.38 $32,384 - $117,392
18,400 New
18,400 $32,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.38B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Ifg Advisory, LLC Portfolio

Follow Ifg Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ifg Advisory, LLC with notifications on news.